Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2013
At a glance
- Drugs Filociclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions; Pharmacokinetics
- 01 Aug 2012 Planned End Date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 05 Mar 2012 Planned End Date changed from 1 Mar 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 16 Sep 2011 New trial record